-
1
-
-
39449095735
-
Infectious Diseases Society of America. Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America
-
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF; Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-360.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 327-360
-
-
Walsh, T.J.1
Anaissie, E.J.2
Denning, D.W.3
Herbrecht, R.4
Kontoyiannis, D.P.5
Marr, K.A.6
Morrison, V.A.7
Segal, B.H.8
Steinbach, W.J.9
Stevens, D.A.10
van Burik, J.A.11
Wingard, J.R.12
Patterson, T.F.13
-
2
-
-
0037371527
-
Voriconazole: A new triazole antifungal agent
-
Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003;36:630-637.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 630-637
-
-
Johnson, L.B.1
Kauffman, C.A.2
-
3
-
-
34548366493
-
Changing epidemiology of rare mould infections: Implications for therapy
-
Malani AN, Kauffman CA. Changing epidemiology of rare mould infections: implications for therapy. Drugs 2007;67:1803-1812.
-
(2007)
Drugs
, vol.67
, pp. 1803-1812
-
-
Malani, A.N.1
Kauffman, C.A.2
-
4
-
-
0038556830
-
-
Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-N,bling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122-1131.
-
Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-N,bling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122-1131.
-
-
-
-
5
-
-
0035176021
-
Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole
-
Denning DW, Griffiths CE. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole. Clin Exp Dermatol 2001;26:648-653.
-
(2001)
Clin Exp Dermatol
, vol.26
, pp. 648-653
-
-
Denning, D.W.1
Griffiths, C.E.2
-
6
-
-
0037043655
-
-
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415.
-
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415.
-
-
-
-
7
-
-
0036498964
-
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
-
Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002;34:563-571.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 563-571
-
-
Denning, D.W.1
Ribaud, P.2
Milpied, N.3
Caillot, D.4
Herbrecht, R.5
Thiel, E.6
Haas, A.7
Ruhnke, M.8
Lode, H.9
-
8
-
-
38449119567
-
Pseudoporphyria associated with voriconazole
-
Kwong WT, Hsu S. Pseudoporphyria associated with voriconazole. J Drugs Dermatol 2007;6:1042-1044.
-
(2007)
J Drugs Dermatol
, vol.6
, pp. 1042-1044
-
-
Kwong, W.T.1
Hsu, S.2
-
9
-
-
10644234678
-
Voriconazole-induced retinoid-like photosensitivity in children
-
Rubenstein M, Levy ML, Metry D. Voriconazole-induced retinoid-like photosensitivity in children. Pediatr Dermatol 2004;21:675-678.
-
(2004)
Pediatr Dermatol
, vol.21
, pp. 675-678
-
-
Rubenstein, M.1
Levy, M.L.2
Metry, D.3
-
11
-
-
33644499705
-
Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl
-
Racette AJ, Roenigk HH Jr, Hansen R, Mendelson D, Park A. Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl. J Am Acad Dermatol 2005;52(5 suppl 1):S81-S85.
-
(2005)
J Am Acad Dermatol
, vol.52
, Issue.5 SUPPL. 1
-
-
Racette, A.J.1
Roenigk Jr, H.H.2
Hansen, R.3
Mendelson, D.4
Park, A.5
-
14
-
-
0036191021
-
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
-
Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002;21:240-248.
-
(2002)
Pediatr Infect Dis J
, vol.21
, pp. 240-248
-
-
Walsh, T.J.1
Lutsar, I.2
Driscoll, T.3
Dupont, B.4
Roden, M.5
Ghahramani, P.6
Hodges, M.7
Groll, A.H.8
Perfect, J.R.9
-
15
-
-
33947507884
-
Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy
-
McCarthy KL, Playford EG, Looke DF, Whitby M. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy. Clin Infect Dis 2007;44:e55-e56.
-
(2007)
Clin Infect Dis
, vol.44
-
-
McCarthy, K.L.1
Playford, E.G.2
Looke, D.F.3
Whitby, M.4
|